Health ❯ Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease Research Treatment Risk Factors Amyloids Genetics Treatment Options Inflammation RNA Interference Diagnosis Brain Cell Death Caregiving Gender Differences Biomarkers SuperAgers Treatment Strategies Research Findings Posterior Cortical Atrophy Transmission of Alzheimer's Disease Early-Onset Alzheimer's Transmissible Dementia APOE4 Lipids APOE Protein Aggregates Gene Length Donanemab Drug Development Research Institutions Vascular Contributions Gut-Brain Axis Preventative Strategies Social Behavior Immune System Cellular Stress Pathology Genetic Factors Impact on Quality of Life Public Health Research Techniques Cell Death Mechanisms Toxins Genetic Risk Factors Brain Damage Brain Regions Therapies Genetic Mutations Protein Aggregation Amyloid-Beta Aggregates Environmental Factors Physical Activity Drug Repurposing Amyloid Precursor Protein Brain Function Causes Viral Infections Pathways to Alzheimer's Brain Cell Loss

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Failure to convert higher progranulin levels into slowed FTD progression is prompting a shift of resources to other trials.

Study Ties Toxic Algae Exposure to Alzheimer’s-Like Brain Changes in Stranded Florida Dolphins